中嘉博创(000889.SZ)终止公开发行可转债并撤回申请文件
格隆汇11月19日丨中嘉博创(000889.SZ)公布,公司于2019年11月18日召开的第七届董事会2019年第十五次会议,审议通过了《关于终止公开发行可转换公司债券事项并撤回申请文件的议案》,公司决定终止公开发行可转换公司债券事项并向中国证监会申请撤回可转债的申请文件
自公司申请此次公开发行可转债以来,公司与中介机构积极有序推进相关工作,但鉴于市场环境和融资政策发生变化,公司综合考虑目前的实际经营情况及资金需求,对比多种融资方案后,经审慎研究,并与中介机构深入沟通后,公司决定终止本次公开发行可转换公司债券事项,并向中国证监会申请撤回相关申请文件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.